Mostrar el registro sencillo del ítem

dc.contributor.author
Bardach, Ariel Esteban  
dc.contributor.author
Palermo, Carolina  
dc.contributor.author
Alconada, Tomás  
dc.contributor.author
Sandoval, Macarena  
dc.contributor.author
Balan, Darío Javier  
dc.contributor.author
Guevara, Javier Nieto  
dc.contributor.author
Gómez, Jorge  
dc.contributor.author
Ciapponi, Agustín  
dc.date.available
2023-09-19T13:06:58Z  
dc.date.issued
2021-08  
dc.identifier.citation
Bardach, Ariel Esteban; Palermo, Carolina; Alconada, Tomás; Sandoval, Macarena; Balan, Darío Javier; et al.; Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis; Public Library of Science; Plos One; 16; 8-2021; 1-19  
dc.identifier.issn
1932-6203  
dc.identifier.uri
http://hdl.handle.net/11336/211998  
dc.description.abstract
The epidemiology and burden of Herpes Zoster (HZ) are largely unknown, and there are no recent reviews summarizing the available evidence from the Latin America and Caribbean (LAC) region. We conducted a systematic review and meta-analysis to characterize the epidemiology and burden of HZ in LAC. Bibliographic databases and grey literature sources were consulted to find studies published (January 2000 ?February 2020) with epidemiological endpoints: cumulative incidence and incidence density (HZ cases per 100,000 person-years), prevalence, case-fatality rates, HZ mortality, hospitalization rates, and rates of each HZ complication. Twenty-six studies were included with most studies coming from Brazil. No studies reported the incidence of HZ in the general population. In population at higher risk, the cumulative incidence ranged from 318?3,423 cases of HZ per 100,000 persons per year of follow-up. The incidence density was 6.4?36.5 cases per 1,000 person-years. Age was identified as a major risk factor towards HZ incidence which increase significantly in people >50 years of age. Hospitalization rates ranged from 3%?35.7%. The in-hospital HZ mortality rate ranged from 0%?36%. Overall, HZ mortality rates were found to be higher in females across all age groups and countries. The incidence of HZ complications (such as post-herpetic neuralgia, ophthalmic herpes zoster, and Ramsay Hunt syndrome) was higher in the immunosuppressed compared to the immunocompetent population. Acyclovir was the most frequently used therapy. Epidemiological data from Ministry of Health databases (Argentina, Brazil, Colombia, Chile y Mexico) and Institute for Health Metrics and Evaluation?s Global Burden of Disease project reported stable rates of hospitalizations and deaths over the last 10 years. High-risk groups for HZ impose a considerable burden in LAC. They could benefit from directed healthcare initiatives, including adult immunization, to prevent HZ occurrence and its complications.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Public Library of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Herpes zoster  
dc.subject
Latin America  
dc.subject
Systematic review  
dc.subject
Meta-analysis  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-09-18T13:31:47Z  
dc.journal.volume
16  
dc.journal.pagination
1-19  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
San Francisco  
dc.description.fil
Fil: Bardach, Ariel Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.description.fil
Fil: Palermo, Carolina. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Alconada, Tomás. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Sandoval, Macarena. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Balan, Darío Javier. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Guevara, Javier Nieto. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Gómez, Jorge. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Ciapponi, Agustín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina  
dc.journal.title
Plos One  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255877  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.pone.0255877